Overview

Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer

Status:
Recruiting
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Qizhu Yuling prescription for postoperative esophagus cancer.
Phase:
N/A
Details
Lead Sponsor:
Jie Li